Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.

Results 1 - 20 of 123 : 1 2 3 4 5 6 7 Next »

Recs

0
Member Avatar optioncoach (91.02) Submitted: 8/23/2015 8:23:34 PM : Outperform Start Price: $184.29 ILMN Score: +2.11

Buying my favorites no matter what. These companies are not going anywhere and some I feel are just plain and simple too cheap. I will continue to sell volatility and buy quality until we cover the shorts and get that snap back rally. I don't see a bear market coming. This is the shake out.

Recs

0
Member Avatar JimmyLocos (34.33) Submitted: 8/21/2015 2:52:57 PM : Outperform Start Price: $200.43 ILMN Score: -0.28

DNA sequencing will continue to grow.

Recs

0
Member Avatar Lightmatter9 (< 20) Submitted: 7/17/2015 6:25:45 PM : Outperform Start Price: $240.84 ILMN Score: -10.31

Excellent management combined with a field of unlimited potential.

Recs

0
Member Avatar BentMike (58.35) Submitted: 7/17/2015 2:29:42 PM : Outperform Start Price: $239.21 ILMN Score: -9.97

Used extensively in academia and professional science on non-human subjects. Good stuff. great future.

Recs

0
Member Avatar gunterle (66.26) Submitted: 7/14/2015 11:17:59 AM : Outperform Start Price: $225.86 ILMN Score: -5.92

signal and Zacks 2

Recs

0
Member Avatar dstwhit (79.46) Submitted: 6/24/2015 11:47:10 AM : Outperform Start Price: $222.97 ILMN Score: -4.38

strong leadership (glassdoor); rb; leader in genome sequencing in biotech industry; high rev/earnings growth and repeat product; innovative culture
but: p/e=77; biotech industry may have a correction coming

Recs

0
Member Avatar Justify (< 20) Submitted: 6/10/2015 1:53:03 PM : Outperform Start Price: $216.02 ILMN Score: -1.80

It's lead in gene sequencing backed by a surge in gene research for curing diseases bodes well.

Recs

0
Member Avatar jdbow (73.10) Submitted: 6/8/2015 10:44:08 AM : Outperform Start Price: $206.88 ILMN Score: +1.37

been thinking about this one for a while & the price took a nice drop today

Recs

0
Member Avatar DLester78 (73.67) Submitted: 6/2/2015 10:56:58 AM : Outperform Start Price: $203.96 ILMN Score: +3.54

Medicine squared

Recs

0
Member Avatar dscrugham (< 20) Submitted: 5/25/2015 7:09:06 PM : Outperform Start Price: $204.36 ILMN Score: +3.86

Great Rule Breaker and growing!!!

Recs

0
Member Avatar horsefeathers (< 20) Submitted: 5/21/2015 2:25:02 PM : Outperform Start Price: $202.94 ILMN Score: +4.92

GROWTH MARKET

Recs

0
Member Avatar aminded45 (< 20) Submitted: 5/11/2015 10:13:00 PM : Outperform Start Price: $195.72 ILMN Score: +6.83

A great product at the right time. With a little regulatory help this stock could be a sure winner.

Recs

0
Member Avatar NickInvestments (28.00) Submitted: 1/30/2015 6:41:41 PM : Outperform Start Price: $195.37 ILMN Score: +2.61

Genetic reading and writing are massive future markets.

Recs

0
Member Avatar mrudolph72 (60.36) Submitted: 1/10/2015 4:56:14 PM : Outperform Start Price: $195.92 ILMN Score: +4.39

2015 Nasdaq Dozen

Recs

0
Member Avatar kirk802 (< 20) Submitted: 12/28/2014 6:22:18 PM : Outperform Start Price: $188.20 ILMN Score: +10.16

Outputs from Illumina's sequencing machines and reagants are the rocket fuel for the arrival of precision medicine treatments for cancer and other diseases. For cancer patients and the related industries, consistency is demanded by the FDA and so is imperative - not optional. Therefore, Illumina will remain the state of the art for many years, with a secure overall market position. And, over the next few years, its outputs will become the de facto standard around which apps will be created. Think of outputs from Illumina as like the DOS that formed the basis of Microsoft. Already, companies like Foundation Medicine and others depend on Illumina to provide the tools to sequence cancer genes and provide recommendations for treatments that are saving lives. Read up about Foundation Medicine (FMI), and then think about what that means for Illumina.

Recs

0
Member Avatar RW (61.08) Submitted: 12/15/2014 2:43:51 PM : Outperform Start Price: $180.01 ILMN Score: +11.04

I like what Illumina stands for so I'm willing to put my money on the line.

Recs

0
Member Avatar lwwjrmd (68.09) Submitted: 12/15/2014 10:45:33 AM : Outperform Start Price: $181.62 ILMN Score: +10.64

GENOME

Recs

0
Member Avatar My535 (42.78) Submitted: 11/28/2014 12:12:09 PM : Outperform Start Price: $189.04 ILMN Score: +9.37

Early mover in genetic testing technology.

Recs

0
Member Avatar Tophinater (23.20) Submitted: 11/21/2014 10:38:53 AM : Outperform Start Price: $187.63 ILMN Score: +10.00

I like the name of the company.

Recs

0
Member Avatar pmarty59 (48.09) Submitted: 11/12/2014 1:13:09 PM : Outperform Start Price: $178.98 ILMN Score: +13.62

Leader in genetic modeling for everyone. Unlimited demand over next decade.

Featured Broker Partners